aTyr Pharma(ATYR)
SAN DIEGO, CAPharmaceutical
Focus: aTyr Pharma is a public-stage biotech focused on therapeutic proteins for respiratory and infectious disease indications. The company is pre-revenue or near-zero revenue with a highly experimental pipeline.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About aTyr Pharma
AI assessmentNot HiringNo open roles listed right now. Follow aTyr Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from aTyr Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$353K
Pipeline & Clinical Trials
A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Lif
Facioscapulohumeral Muscular DystrophyClinical Trials (1)
NCT01437345A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD
N/AHelp build intelligence for aTyr Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.